Last reviewed · How we verify
Ceftin (CEFUROXIME AXETIL)
Ceftin works by inhibiting the bacterial enzyme responsible for cell wall synthesis, ultimately leading to bacterial cell death.
At a glance
| Generic name | CEFUROXIME AXETIL |
|---|---|
| Sponsor | GSK |
| Drug class | Cephalosporin Antibacterial |
| Modality | Small molecule |
| Therapeutic area | Infectious Disease |
| Phase | FDA-approved |
| First approval | 1987 |
Mechanism of action
Cefuroxime axetil is an antibacterial drug see Clinical Pharmacology (12.4)].
Approved indications
- Acute bacterial sinusitis
- Acute exacerbation of chronic bronchitis
- Acute gonococcal cervicitis
- Acute gonococcal endometritis
- Acute gonococcal urethritis
- Acute maxillary sinusitis
- Acute otitis media
- Bacterial pneumonia
- Bacterial urinary infection
- Escherichia coli urinary tract infection
- Gonorrhea
- Gonorrhea of rectum
- Haemophilus Influenzae Acute Otitis Media
- Haemophilus Influenzae Bronchitis
- Haemophilus Influenzae Chronic Bronchitis
- Haemophilus Parainfluenzae Bronchitis
- Haemophilus Parainfluenzae Chronic Bronchitis
- Haemophilus influenzae pneumonia
- Impetigo
- Infection due to Staphylococcus aureus
Common side effects
- Diarrhea
- Jarisch-Herxheimer reaction
- Vaginitis
- Nausea/Vomiting
- Hemolytic anemia
- Leukopenia
- Pancytopenia
- Thrombocytopenia
- Pseudomembranous colitis
- Hepatitis
- Cholestasis
- Jaundice
Key clinical trials
- Effects of Red and Infrared Photobiomodulation in Rhinoplasty at a Single Centre (NA)
- Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing (PHASE2)
- Short-course Antibiotics vs Standard Course Antibiotics in Patients With Cholangitis (NA)
- Clindamycin as an Alternative to Vancomycin in Patients Undergoing Aortic Cardiac Surgery With Extracorporeal Circulation (ECC) (PHASE2)
- Prevention of Surgical Site Infection in Open Paediatric Groin Surgeries Using Intravenous Prophylactic Antibiotics and Antimicrobial-coated Sutures (NA)
- Pivmecillinam as Oral Step-Down Treatment for Escherichia Coli Febrile Urinary Tract Infection Versus Standard of Care (PHASE4)
- Compound Phellodendron Decoction May Promote Wound Healing After Anal Fistulotomy (NA)
- Effect of Topical Sinonasal Antibiotics (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ceftin CI brief — competitive landscape report
- Ceftin updates RSS · CI watch RSS
- GSK portfolio CI